Interaction of ACTH, corticosterone and cyclic nucleotides in Harding-Passey melanoma melanogenesis.
The acute in vitro action of adrenocorticotropin (ACTH) and corticosterone alone and in combination were determined in the Harding-Passey (HP) melanoma grown in vivo. Hormone treated melanoma dice (5--240 min) were analyzed for tyrosinase activity, cyclic AMP (cAMP) and cyclic GMP (cGMP). ACTH elevated cAMP and cGMP levels 20- and 13-fold, respectively, in the HP melanoma. However, these large increases in cyclic nucleotide levels were accompanied by only a 49% increase in tyrosinase activity. Corticosterone elicited a similar response. ACTH plus corticosterone produced an early cAMP and cGMP peak followed by depression. ACTH plus corticosterone stimulated tyrosinase activity coincident with the early cyclic nucleotide peak followed by a drop in tyrosinase activity which was subsequently elevated. The results indicate that neither cAMP nor cGMP are the sole modulators of tyrosinase activity and suggest the interaction of ACTH, corticosterone and cyclic nucleotides in the regulation of melanoma tyrosinase activity.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D003345:Corticosterone / Q000494:pharmacology*; D000242:Cyclic AMP / Q000032:analysis; D006152:Cyclic GMP / Q000032:analysis; D004347:Drug Interactions; D066298:In Vitro Techniques; D008545:Melanoma / Q000032:analysis / Q000201:enzymology / Q000378:metabolism*; D051379:Mice; D014442:Monophenol Monooxygenase / Q000032:analysis; D009374:Neoplasms, Experimental / Q000378:metabolism; D009712:Nucleotides, Cyclic / Q000032:analysis*
D009712:Nucleotides, Cyclic; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D014442:Monophenol Monooxygenase; D006152:Cyclic GMP; D003345:Corticosterone